coronary stenosis

Orbital Atherectomy improves calcified lesions treatment outcomes

Original title:&nbsp;Pivotal Trial to Evaluate the Safety and Efficacy of the Orbital Atherectomy System in Treating de Novo, Severely Calcified Coronary Lesions (ORBIT II)&nbsp;Reference:&nbsp;Jeffrey Chambers, et al. JACC Intervention 2014;7:510-8 Severely calcified coronary lesions, traditionally associated to difficult or impossible stent implantation, asymmetric stent expansion, higher post procedural events rate, more restenosis, more lesion revascularization,<a href="https://solaci.org/en/2014/06/02/orbital-atherectomy-improves-calcified-lesions-treatment-outcomes/" title="Read more" >...</a>

Dedicated two everolimus eluting stent strategies improve bifurcation PCI outcomes

Original title:&nbsp;Dedicated two-stents technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: The EES-bifurction study.&nbsp;Reference:&nbsp;Nisharamed I. Kherada, et al. International Journal of Cardiology 2014;174:13-17 &nbsp; Bifurcation PCI, especially 1.1.1 Medina bifurcation lesions PCI, is particularly challenging and has been associated with increased restenosis. The use of drug eluting stents (DES) associated to<a href="https://solaci.org/en/2014/05/27/dedicated-two-everolimus-eluting-stent-strategies-improve-bifurcation-pci-outcomes/" title="Read more" >...</a>

The length of the stent is not an event predictor with the new generation of DES. It is the end of the Spot stenting?

Original title:&nbsp;Impact of the Stent Length on Long-Term Clinical Outcomes Following Newer-Generation Drug-Eluting Stent Implantation.&nbsp;Reference:&nbsp;Ik Jun Choi et al. Am J Cardiol 2014;113:457-464. Completely cover the lesion with a sufficiently long stent has been the preferred strategy that emerged from drug-eluting stents (DES). However, for the first-generation DES stent length has been a predictor of<a href="https://solaci.org/en/2014/02/20/the-length-of-the-stent-is-not-an-event-predictor-with-the-new-generation-of-des-it-is-the-end-of-the-spot-stenting/" title="Read more" >...</a>

Renal angioplasty versus medical treatment, no clinical benefit and only a modest help to control blood pressure

Original title:&nbsp;Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis. CORAL trial.&nbsp;Reference:&nbsp;Christopher J. Cooper et al. DOI: 10.1056/NEJMoa1310753 &nbsp; Between 1 and 5% of the hypertensive population has renal artery stenosis and in general, this is combined with peripheral and coronary vascular disease. The renal artery stenosis may result in hypertension, ischemic nephropathy, and multiple long-term<a href="https://solaci.org/en/2013/11/26/renal-angioplasty-versus-medical-treatment-no-clinical-benefit-and-only-a-modest-help-to-control-blood-pressure/" title="Read more" >...</a>

Clinical factors to help decide between angioplasty and carotid endarterectomy

Original title:&nbsp;A clinical rule (sex, contralateral occlusion, age, and restenosis) to select patients for stenting versus carotid endarterectomy: Systematic review of observational studies with validation in randomized trials.&nbsp;Reference:&nbsp;Touz&eacute; E et al. Stroke. 2013;Epub ahead of print Compared with carotid endarterectomy, angioplasty with stent is associated with an increased risk of pre- procedural stroke especially for<a href="https://solaci.org/en/2013/11/12/clinical-factors-to-help-decide-between-angioplasty-and-carotid-endarterectomy/" title="Read more" >...</a>

Intravascular imaging for event prediction: looking beyond the lumen.

Original title:&nbsp;Thinking Out of the Lumen: FFR Vs. Intravascular Imaging for MACE Prediction.&nbsp;Reference:&nbsp;Pedro R. Moreno et al.&nbsp;J Am Coll Cardiol, article in press. Intravascular imaging studies have shown that the lesions most likely to produce coronary events usually have modest luminal stenosis, large cap burden and thin fibrous cap. These plaques will evolve into a<a href="https://solaci.org/en/2013/09/05/intravascular-imaging-for-event-prediction-looking-beyond-the-lumen/" title="Read more" >...</a>

Multislice computed tomography for bioresorbable scaffolds: the end of invasive diagnostic studies?

Original title:&nbsp;Multislice Computed Tomography Angiography for Non-invasive Assessment of the 18-Months Performance of a Novel Radiolucent Bioresorbable Vascular Scaffolding Device (ABSORB Trial).&nbsp;Reference:&nbsp;Koen Nieman et al. J Am Coll Cardiol, article in press. Metal stents revolutionized coronary angioplasty procedures; however, they are permanent prosthetic devices that make re intervention difficult and prolongue thrombosis risk. This problem<a href="https://solaci.org/en/2013/08/14/multislice-computed-tomography-for-bioresorbable-scaffolds-the-end-of-invasive-diagnostic-studies/" title="Read more" >...</a>

Carotid angioplasty prior to central venous catheter. The best option to solve combined problems.

Original title:&nbsp;A Direct Comparison of Early and Late Outcomes with Three Approaches to Carotid Revascularization and Open Heart Surgery.&nbsp;Reference:&nbsp;Mehdi H. Shishehbor et al. J Am Coll Cardiol, article in press. &nbsp; The prevalence of severe carotid stenosis (&gt; 80%) in patients planning to have a Central Venous Catheter (CVC) is estimated at between 6 and<a href="https://solaci.org/en/2013/08/08/carotid-angioplasty-prior-to-central-venous-catheter-the-best-option-to-solve-combined-problems/" title="Read more" >...</a>

High doses of statins may reduce the lipid content in severe injury

Original title:&nbsp;Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy. The YELLOW Trial (Reduction in Yellow Plaque by Aggressive Lipid-Lowering Therapy).&nbsp;Reference:&nbsp;Annapoorna S. Kini et al. J Am Coll Cardiol 2013;62:21&ndash;9. Multiple studies have shown the benefits of statins in reducing all events, stabilize plaques and improve endothelial function. Coronary intravascular ultrasound (IVUS)<a href="https://solaci.org/en/2013/07/15/high-doses-of-statins-may-reduce-the-lipid-content-in-severe-injury/" title="Read more" >...</a>

Double DES in bifurcations, double thrombosis risk

Original title:&nbsp;Late Thrombosis After Double Versus Single Drug-Eluting Stent in the Treatment of Coronary Bifurcations A Meta-analysis of Randomized and Observational Studies.&nbsp;Reference:&nbsp;Marco Zimarino et al. J Am Coll Cardiol Intv 2013. Article in press. In the era of drug-eluting stents, (DES), several randomized and observational studies have been conducted trying to find the best strategy<a href="https://solaci.org/en/2013/06/14/double-des-in-bifurcations-double-thrombosis-risk/" title="Read more" >...</a>

Top